PNUFEXIV
Live / Registered — Registered (as of 17 Dec 2024)
What this means for you
Registered since 17 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98383876
- Registration number
- 7608352
- Mark type
- Stylized text
- Filed
- 31 Jan 2024
- Published for opposition
- 15 Oct 2024
- Registered
- 17 Dec 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 17 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2024 — PUBLISHED FOR OPPOSITION
- 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 27 Aug 2024 — LETTER OF SUSPENSION E-MAILED
- 27 Aug 2024 — SUSPENSION LETTER WRITTEN
- 27 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 27 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 27 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 24 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Aug 2024 — NON-FINAL ACTION E-MAILED